Target intelligence / Profile preview

Complement component 1 Q subcomponent-like 1 (C1QL1)

Target
C1QL1
Molecular classification
Other (secreted synaptic protein; C1q family)
01

Overview

Complement component 1 Q subcomponent-like 1 (C1QL1) is a secreted protein of the C1q family involved in diverse biological processes, especially in the central nervous system[1][2][3]. It is released by specific projection neurons such as climbing fibers in the cerebellum, where it binds to the adhesion G protein-coupled receptor BAI3 on Purkinje cells, orchestrating synapse formation, refinement, and maintenance critical for motor learning and proper synaptic connectivity[1][2][3]. C1QL1 is also present in the auditory system (cochlear hair cells), where it may support synaptic maintenance in sensory pathways[1]. Beyond the nervous system, C1QL1 exerts proangiogenic effects, promoting endothelial cell migration and vessel formation via ERK1/2 pathway activation[1]. In oncology, increased C1QL1 expression has been linked to tumor progression, invasiveness, and poor prognosis in lung adenocarcinoma and as a glioma-promoting factor, making it a possible therapeutic target and disease biomarker[1]. Its conserved RNA editing suggests finely tuned post-transcriptional regulation, with diverse roles in health and disease[1][2][3][6].

Other names
C1q-related factorC1QL1C1QRFCRFCTRP14C1q/TNF-related protein 14C1QTNF14Complement component 1 Q subcomponent-like 1
02

Biological functions

Synapse formationSynapse maintenanceMaintenance of synapse structureMotor learningNeuron remodelingSignaling receptor bindingRegulation of synapse pruningVascular remodeling/proangiogenic activity
03

Disease associations

Cancer (e.g., lung adenocarcinoma, glioma)Deafness (autosomal recessive 25)Autism spectrum disorderNeurodevelopmental/neurological disorders
04

Safety considerations

Potential roles in oncogenic processes (tumor growth, invasion, EMT)Alteration of neural circuit function if targeted
05

Biomarkers

Elevated expression as a prognostic biomarker in certain cancers (e.g., lung adenocarcinoma, glioma)

Beyond the preview

Go deeper on Complement component 1 Q subcomponent-like 1 (C1QL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement component 1 Q subcomponent-like 1 (C1QL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call